Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Daniel J. Drucker(University of Toronto), John B. Buse(University of North Carolina at Chapel Hill), Kristin Taylor, David M. Kendall, Michael Trautmann(Eli Lilly (United States)), Dongliang Zhuang, Lisa A. Porter
Cited by 1,068
Abstract
Related Papers
No related papers found
Powered by citation graph analysis